The medicine for schizophrenia Abilify has got to attention of experts, let out by company Bristol Myers Squibb Co. Clinical tests have shown its toxicity and harm for a liver. Also the preparation for growing thin Xenical from Roche Holding AG in connection with risk of a rectal bleeding is surveyed.

Preparation occurrence in this list does not mean, that FDA declares existing risk in medicine use. It means, that experts had been found out a problem, but relationships of cause and effect between a preparation and harm for health are not established yet, - is spoken in the organisation report.

The list also included antidepressants - inhibitors of return capture of a serotonin and Noradrenalinum - in connection with risk of congenital anomalies; Lamisil from Novartis AG and Lariam (a preparation from a malaria) from Roche because of risk of alienations; Diovan, the preparation from the raised pressure, from Novartis AG, possibly, is bound to anaemia development; Plan B (oral contraceptives) from Teva Pharmaceutical Industries are bound to risk of a loss of consciousness.

The list of medicines under the control over a foodstuff and medicinal preparations will update Management each three months.